Abstract
The extracellular matrix (ECM) regulates the development and maintains tissue homeostasis. The ECM is composed of a complex network of molecules presenting distinct biochemical properties to regulate cell growth, survival, motility, and differentiation. Among their components, proteoglycans (PGs) are considered one of the main components of ECM. Its composition, biomechanics, and anisotropy are exquisitely tuned to reflect the physiological state of the tissue. The loss of ECM’s homeostasis is seen as one of the hallmarks of cancer and, typically, defines transitional events in tumor progression and metastasis. In this chapter, we discuss the types of proteoglycans and their roles in cancer. It has been observed that the amount of some ECM components is increased, while others are decreased, depending on the type of tumor. However, both conditions corroborate with tumor progression and malignancy. Therefore, ECM components have an increasingly important role in carcinogenesis and this leads us to believe that their understanding may be a key in the discovery of new anti-tumor therapies. In this book, the main ECM components will be discussed in more detail in each chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrink M, Grujic M, Pejler G (2004) Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem 279:40897–40905
Adams JC, Lawler J (2011) The thrombospondins. Cold Spring Harb Perspect Biol 3:a009712. https://doi.org/10.1101/cshperspect.a009712
Adini I, Ghosh K, Adini A et al (2014) Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment. J Clin Invest 124:425. https://doi.org/10.1172/JCI69404
Agrawal D (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94:513. https://doi.org/10.1093/jnci/94.7.513
Albo D, Berger DH, Wang TN et al (1997) Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system. Surgery 122(2):493–499
Albo D, Shinohara T, Tuszynski GP (2002) Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J Surg Res 108:51. https://doi.org/10.1006/jsre.2002.6452
Alexander CM, Reichsman F, Hinkes MT et al (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25:329. https://doi.org/10.1038/77108
Alexopoulou AN, Multhaupt HAB, Couchman JR (2007) Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 39:505
Antoniali G, Serra F, Lirussi L, Tanaka M, D’Ambrosio C, Zhang S, Radovic S, Dalla E, Ciani Y, Scaloni A, Li M, Piazza S, Tell G (2017) Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. Nat Commun 8(1):797. https://doi.org/10.1038/s41467-017-00842-8
Araki K, Wakabayashi H, Shintani K et al (2009) Decorin suppresses bone metastasis in a breast cancer cell line. Oncology 77:92–99. https://doi.org/10.1159/000228253
Archakov AI, Govorun VM, Dubanov AV, Ivanov YD, Veselovsky AV, Lewi P, Janssen P (2003) Protein-protein interactions as a target for drugs in proteomics. Proteomics 3:380–391
Aznavoorian S, Stracke ML, Krutzsch H et al (1990) Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110:1427. https://doi.org/10.1083/jcb.110.4.1427
Bae YK, Kim A, Kim MK et al (2013) Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. Hum Pathol 44:2028. https://doi.org/10.1016/j.humpath.2013.03.006
Baghy K, Tátrai P, Regös E, Kovalszky I (2016) Proteoglycans in liver cancer. World J Gastroenterol 22:379
Baik MG, Lee MJ, Choi YJ (1998) Gene expression during involution of mammary gland (review). Int J Mol Med 2:39–44
Balanis N, Wendt MK, Schiemann BJ et al (2013) Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. J Biol Chem 288:17954. https://doi.org/10.1074/jbc.M113.475277
Bao S, Ouyang G, Bai X et al (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5:329. https://doi.org/10.1016/S1535-6108(04)00081-9
Bao LH, Sakaguchi H, Fujimoto J, Tamaya T (2007) Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci 14:373. https://doi.org/10.1007/s11373-006-9143-1
Barbareschi M, Maisonneuve P, Aldovini D et al (2003) High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 98:474–483. https://doi.org/10.1002/cncr.11515
Baril P, Gangeswaran R, Mahon PC et al (2007) Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3k pathway. Oncogene 26:2082. https://doi.org/10.1038/sj.onc.1210009
Beauvais DM, Burbach BJ, Rapraeger AC (2004) The syndecan-1 ectodomain regulates αvβ3 integrin activity in human mammary carcinoma cells. J Cell Biol 167:171. https://doi.org/10.1083/jcb.200404171
Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC (2009) Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J Exp Med 206:691–705. https://doi.org/10.1084/jem.20081278
Beliveau A, Mott JD, Lo A et al (2010) Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo. Genes Dev 24:2800. https://doi.org/10.1101/gad.1990410
Benassi MS, Pazzaglia L, Chiechi A et al (2009) NG2 expression predicts the metastasis formation in soft-tissue sarcoma patients. J Orthop Res 27:135. https://doi.org/10.1002/jor.20694
Benton G, George J, Kleinman HK, Arnaoutova IP (2009) Advancing science and technology via 3D culture on basement membrane matrix. J Cell Physiol 221:18
Berendsen AD, Pinnow EL, Maeda A et al (2014) Biglycan modulates angiogenesis and bone formation during fracture healing. Matrix Biol 35:223. https://doi.org/10.1016/j.matbio.2013.12.004
Bernabeu C, Lopez-Novoa JM, Quintanilla M (2009) The emerging role of TGF-β superfamily coreceptors in cancer. Biochim Biophys Acta 1792:954
Bilandzic M, Stenvers KL (2011) Betaglycan: a multifunctional accessory. Mol Cell Endocrinol 339:180–189. https://doi.org/10.1016/J.MCE.2011.04.014
Bissell MJ, Kenny PA, Radisky DC (2005) Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 70:343–356
Bix G, Castello R, Burrows M et al (2006) Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst 98:1634. https://doi.org/10.1093/jnci/djj441
Blanco-Mezquita JT, Hutcheon AEK, Zieske JD (2013) Role of thrombospondin-1 in repair of penetrating corneal wounds. Invest Ophthalmol Vis Sci 54:6262–6268. https://doi.org/10.1167/iovs.13-11710
Bondeson L, Lindholm K (1997) Prediction of invasiveness by aspiration cytology applied to nonpalpable breast carcinoma and tested in 300 cases. Diagn Cytopathol 17:315. https://doi.org/10.1002/(SICI)1097-0339(199711)17:5<315::AID-DC2>3.0.CO;2-9
Bonnet N, Garnero P, Ferrari S (2016) Periostin action in bone. Mol Cell Endocrinol 432:75. https://doi.org/10.1016/j.mce.2015.12.014
Boot-Handford RP, Tuckwell DS (2003) Fibrillar collagen: the key to vertebrate evolution? A tale of molecular incest. Bioessays 25(2):142–151
Bornstein P (1995) Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 130:503. https://doi.org/10.1083/jcb.130.3.503
Bornstein P, Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14:608
Borsi L, Carnemolla B, Nicolò G et al (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int J Cancer 52:688. https://doi.org/10.1002/ijc.2910520504
Bouck N, Stellmach V, Hsu SC (1996) How tumors become angiogenic. Adv Cancer Res 69:135–174
Boyd NF, Martin LJ, Yaffe MJ, Minkin S (2011) Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 13:223
Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049
Braga T, Grujic M, Lukinius A, Hellman L, Abrink M, Pejler G (2007) Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. Biochem J 403:49–57
Brar PK, Dalkin BL, Weyer C et al (2003) Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubetal benign prostate glands and adult benign and malignant prostate glands. Prostate 55:65. https://doi.org/10.1002/pros.10206
Bredrup C, Knappskog PM, Majewski J et al (2005) Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Investig Ophthalmol Vis Sci 46:420. https://doi.org/10.1167/iovs.04-0804
Brehme M, Vidal M (2010) A global protein–lipid interactome map. Mol Syst Biol 6:443
Brézillon S, Radwanska A, Zeltz C et al (2009) Lumican core protein inhibits melanoma cell migration via alterations of focal adhesion complexes. Cancer Lett 283:92. https://doi.org/10.1016/j.canlet.2009.03.032
Brown LF, Guidi AJ, Schnitt SJ et al (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5(5):1041–1056
Buchanan C, Stigliano I, Garay-Malpartida HM et al (2010) Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat 119:559–574. https://doi.org/10.1007/s10549-009-0362-9
Buraschi S, Pal N, Tyler-Rubinstein N et al (2010) Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels. J Biol Chem 285:42075–42085. https://doi.org/10.1074/jbc.M110.172841
Buraschi S, Neill T, Goyal A et al (2013) Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci 110:E2582. https://doi.org/10.1073/pnas.1305732110
Capurro M, Martin T, Shi W, Filmus J (2014) Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. J Cell Sci 127:1565. https://doi.org/10.1242/jcs.140871
Caputo S, Bellone M (2018) Osteopontin and the immune system: another brick in the wall. Cell Mol Immunol 15:405
Cardoso AL, Fernandes A, Aguilar-Pimentel JA et al (2018) Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev 47:214
Carnemolla B, Castellani P, Ponassi M et al (1999) Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am J Pathol 154:1345. https://doi.org/10.1016/S0002-9440(10)65388-6
Carpenter PM, Dao AV, Arain ZS et al (2009) Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). Mol Cancer Res 7:462. https://doi.org/10.1158/1541-7786.mcr-08-0148
Carsons SE (2018) Fibronectin in health and disease. CRC Press, Boca Raton
Carter WG, Ryan MC, Gahr PJ (1991) Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes. Cell 65:599. https://doi.org/10.1016/0092-8674(91)90092-D
Cattaruzza S, Schiappacassi M, Kimata K et al (2004) The globular domains of PG-M/versican modulate the proliferation–apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18:779–781. https://doi.org/10.1096/fj.03-0660fje
Cattaruzza S, Nicolosi PA, Braghetta P et al (2013) NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion. J Mol Cell Biol 5:176–193. https://doi.org/10.1093/jmcb/mjt010
Chakraborty S, Hong W (2018) Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond. Cancers (Basel) 10(2):pii: E45
Chakraborty G, Jain S, Patil TV, Kundu GC (2008) Down-regulation of osteopontin attenuates breast tumour progression in vivo. J Cell Mol Med 12:2305. https://doi.org/10.1111/j.1582-4934.2008.00263.x
Chang C, Goel HL, Gao H et al (2015) A laminin 511 matrix is regulated by Taz and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells. Genes Dev 29:1. https://doi.org/10.1101/gad.253682.114
Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB (2008) The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 27(39):5182–5194
Chen C, Wang XF, Sun LZ (1997) Expression of transforming growth factor β (TGFβ) type III receptor restores autocrine TGFβ1 activity in human breast cancer MCF-7 cells. J Biol Chem 272:12862. https://doi.org/10.1074/jbc.272.19.12862
Chen YW, Zhao P, Borup R, Hoffman EP (2000) Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151:1321. https://doi.org/10.1083/jcb.151.6.1321
Chen S, Young MF, Chakravarti S, Birk DE (2014) Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. Matrix Biol 35:103. https://doi.org/10.1016/j.matbio.2014.01.004
Chia J, Kusuma N, Anderson R et al (2007) Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer. Am J Pathol 170:2135. https://doi.org/10.2353/ajpath.2007.060709
Chiquet-Ehrismann R, Chiquet M (2003) Tenascins: regulation and putative functions during pathological stress. J Pathol 200:488
Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131. https://doi.org/10.1016/0092-8674(86)90374-0
Chong HC, Tan CK, Huang RL, Tan NS (2012) Matricellular proteins: a sticky affair with cancers. J Oncol 2012:351089
Chu LH, Chen BS (2008) Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets. BMC Syst Biol 2:56. https://doi.org/10.1186/1752-0509-2-56
Chung CY, Murphy-Ullrich JE, Erickson HP (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7:883. https://doi.org/10.1091/mbc.7.6.883
Clark RA (1989) Fibronectin. Cell 59:775–776. https://doi.org/10.1016/0092-8674(89)90599-0
Clause KC, Barker TH (2013) Extracellular matrix signaling in morphogenesis and repair. Curr Opin Biotechnol 24:830
Condeelis J, Segall JE (2003) Intravital imaging of cell movement in tumours. Nat Rev Cancer 3:921
Contié S, Voorzanger-Rousselot N, Litvin J et al (2011) Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases. Int J Cancer 128:352. https://doi.org/10.1002/ijc.25591
Contreras-Ruiz L, Regenfuss B, Mir FA et al (2013) Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren’s syndrome. PLoS One 8:e75937. https://doi.org/10.1371/journal.pone.0075937
Cooper SJ, Zou H, Legrand SN et al (2010) Loss of type III transforming growth factor-Β receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma. Oncogene 29:2905. https://doi.org/10.1038/onc.2010.64
Coquerel B, Poyer F, Torossian F et al (2009) Elastin-derived peptides: matrikines critical for glioblastoma cell aggressiveness in a 3-D system. Glia 57:1716. https://doi.org/10.1002/glia.20884
Couchman JR (2010) Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol 26:89. https://doi.org/10.1146/annurev-cellbio-100109-104126
Couchman JR, Gopal S, Lim HC et al (2015) Syndecans: from peripheral coreceptors to mainstream regulators of cell behaviour. Int J Exp Pathol 96(1):1. https://doi.org/10.1111/IEP.12112
Csordas G, Santra M, Reed CC et al (2000) Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 275:32879. https://doi.org/10.1074/jbc.M005609200
D’Onofrio M-F, Brézillon S, Baranek T et al (2008) Identification of β1 integrin as mediator of melanoma cell adhesion to lumican. Biochem Biophys Res Commun 365:266–272. https://doi.org/10.1016/j.bbrc.2007.10.155
Dahinden C, Ingold B, Wild P et al (2010) Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res 16:88. https://doi.org/10.1158/1078-0432.CCR-09-0260
Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265(5178):1582–1584. https://doi.org/10.1126/science.7521539
Davies JE, Tang X, Denning JW et al (2004) Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries. Eur J Neurosci 19:1226. https://doi.org/10.1111/j.1460-9568.2004.03184.x
Dawson DW, Pearce SFA, Zhong R et al (1997) CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 138:707. https://doi.org/10.1083/jcb.138.3.707
de Fraipont F, Nicholson AC, Feige J-J, Van Meir EG (2001) Thrombospondins and tumor angiogenesis. Trends Mol Med 7:401–407. https://doi.org/10.1016/S1471-4914(01)02102-5
De Luca A, Santra M, Baldi A et al (1996) Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 271(31):18961–18965. https://doi.org/10.1074/jbc.271.31.18961
De Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24–37
del Pozo Martin Y, Park D, Ramachandran A et al (2015) Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization. Cell Rep 13:2456–2469. https://doi.org/10.1016/j.celrep.2015.11.025
Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7:1475
Desgrosellier JS, Cheresh DA (2010) Erratum: Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10:890. https://doi.org/10.1038/nrc2965
Devy J, Duca L, Cantarelli B et al (2010) Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase. Br J Cancer 103:1562. https://doi.org/10.1038/sj.bjc.6605926
Donet M, Brassart-Pasco S, Salesse S et al (2014) Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism. Br J Cancer 111:139–148. https://doi.org/10.1038/bjc.2014.239
Douglass S, Goyal A, Iozzo RV (2015) The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy. Connect Tissue Res 56:381
Du WW, Yang W, Yee AJ (2013) Roles of versican in cancer biology—tumorigenesis, progression and metastasis. Histol Histopathol 28(6):701–713. https://doi.org/10.14670/HH-28.701
Dueck M, Riedl S, Hinz U et al (1999) Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases. Int J Cancer 82:477. https://doi.org/10.1002/(SICI)1097-0215(19990812)82:4<477::AID-IJC2>3.0.CO;2-5
Dunkman AA, Buckley MR, Mienaltowski MJ et al (2013) Decorin expression is important for age-related changes in tendon structure and mechanical properties. Matrix Biol 32:3. https://doi.org/10.1016/j.matbio.2012.11.005
Duque Lasio ML, Kozel BA (2018) Elastin-driven genetic diseases. Matrix Biol 71–72:144
Dwyer CA, Bi WL, Viapiano MS, Matthews RT (2014) Brevican knockdown reduces late-stage glioma tumor aggressiveness. J Neuro-Oncol 120:63. https://doi.org/10.1007/s11060-014-1541-z
Egeblad M, Rasch MG, Weaver VM (2010a) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22:697
Egeblad M, Rasch MG, Weaver VM et al (2010b) Dynamic interplay between the collagen scaffold and tumor evolution. This review comes from a themed issue on cell-to-cell contact and extracellular matrix Edited by. Curr Opin Cell Biol 22:697. https://doi.org/10.1016/j.ceb.2010.08.015
Elliott JF, Miller CL, Pohajdak B, Talbot D, Helgason CD, Bleackley RC et al (1993) Induction of a proteoglycan core protein mRNA in mouse T lymphocytes. Mol Immunol 30:749–754
Engbring JA, Kleinman HK (2003) The basement membrane matrix in malignancy. J Pathol 200:465
Engel J, Paulsson M, Taylor W et al (1987) Calcium binding domains and calcium-induced conformational transition of SPARC/BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues. Biochemistry 26:6958. https://doi.org/10.1021/bi00396a015
Engvall E, Wewer UM (1996) Domains of laminin. J Cell Biochem 61:493–501. https://doi.org/10.1002/(SICI)1097-4644(19960616)61:4<493::AID-JCB2>3.0.CO;2-J
Eshchenko TY, Rykova VI, Chernakov AE et al (2007) Expression of different proteoglycans in human breast tumors. Biochemistry (Mosc) 72:1016–1020
Farnedi A, Rossi S, Bertani N et al (2015) Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors. BMC Cancer 15:352. https://doi.org/10.1186/s12885-015-1336-4
Feng F, Rittling SR (2000) Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency. Breast Cancer Res Treat 63:71–79
Fernandez-Garcia B, Eiró N, Marín L et al (2014) Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology 64:512. https://doi.org/10.1111/his.12300
Filmus J, Capurro M (2013) Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma. FEBS J 280:2471
Filmus J, Capurro M, Rast J (2008) Glypicans. Genome Biol 9:224. https://doi.org/10.1186/gb-2008-9-5-224
Firlej V, Mathieu JRR, Gilbert C et al (2011) Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res 71:7649–7658. https://doi.org/10.1158/0008-5472.CAN-11-0833
Fontana A, Filleur S, Guglielmi J et al (2005) Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo. Int J Cancer 116:686. https://doi.org/10.1002/ijc.20584
Forootan SS, Foster CS, Aachi VR et al (2006) Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 118:2255. https://doi.org/10.1002/ijc.21619
Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92:679–690. https://doi.org/10.1002/jcb.20091
Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123:4195. https://doi.org/10.1242/jcs.023820
Franz M, Wolheim A, Richter P et al (2010) Stromal laminin chain distribution in normal, hyperplastic and malignant oral mucosa: relation to myofibroblast occurrence and vessel formation. J Oral Pathol Med 39(4):290–298. https://doi.org/10.1111/j.1600-0714.2009.00840.x
Frazier WA, Roberts DD (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54(24):6504–6511
Fried K, Sime W, Lillesaar C et al (2005) Laminins 2 (α2β1γ1, Lm-211) and 8 (α4β1γ 1, Lm-411) are synthesized and secreted by tooth pulp fibroblasts and differentially promote neurite outgrowth from trigeminal ganglion sensory neurons. Exp Cell Res 307:329. https://doi.org/10.1016/j.yexcr.2005.04.009
Frieser M, Nöckel H, Pausch F et al (1997) Cloning of the mouse laminin α4 cDNA. Expression in a subset of endothelium. Eur J Biochem 246:727. https://doi.org/10.1111/j.1432-1033.1997.t01-1-00727.x
Fujita M, Khazenzon NM, Bose S et al (2005) Overexpression of β1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 7:R411. https://doi.org/10.1186/bcr1011
Fukai N, Kenagy RD, Chen L, Gao L, Daum G, Clowes AW (2009) Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia. Arterioscler Thromb Vasc Biol 29:1356–1362
Geberhiwot T, Ingerpuu S, Pedraza C et al (1999) Blood platelets contain and secrete laminin-8 (α4β1γ1) and adhere to laminin-8 via α6β1 integrin. Exp Cell Res 253:723. https://doi.org/10.1006/excr.1999.4653
Gelse K, Pöschl E, Aigner T (2003) Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev 55:1531
Ghajar CM, Peinado H, Mori H et al (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15:807. https://doi.org/10.1038/ncb2767
Giachelli CM, Schwartz SM, Liaw L (1995) Molecular and cellular biology of osteopontin: potential role in cardiovascular disease. Trends Cardiovasc Med 5:88–95. https://doi.org/10.1016/1050-1738(95)00005-T
Giancotti FG (1996) Signal transduction by the alpha 6 beta 4 integrin: charting the path between laminin binding and nuclear events. J Cell Sci 109(Pt 6):1165–1172
Giannelli G, Astigiano S, Antonaci S et al (2002) Role of the α3β1 and α6β4 integrins in tumor invasion. Clin Exp Metastasis 19:217
Giuriato S, Ryeom S, Fan AC et al (2006) Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc Natl Acad Sci 103:16266–16271. https://doi.org/10.1073/PNAS.0608017103
Goldoni S, Humphries A, Nyström A et al (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 185:743. https://doi.org/10.1083/jcb.200901129
Gómez-Herrera Z, Molina-Frechero N, Damián-Matsumura P, Bologna-Molina R (2018) Proteoglycans as potential biomarkers in odontogenic tumors. J Oral Maxillofac Pathol 22:98–103. https://doi.org/10.4103/jomfp.JOMFP_151_17
Gonzales M, Weksler B, Tsuruta D et al (2001) Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol Biol Cell 12:85. https://doi.org/10.1091/mbc.12.1.85
Gordon MK, Hahn RA (2010) Collagens. Cell Tissue Res 339:247–257. https://doi.org/10.1007/s00441-009-0844-4
Götte M (2003) Syndecans in inflammation. FASEB J 17:575–591. https://doi.org/10.1096/fj.02-0739rev
Götte M, Kersting C, Ruggiero M et al (2006) Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer. Anticancer Res 26:621–627
Greenwood JA, Murphy-Ullrich JE (1998) Signaling of de-adhesion in cellular regulation and motility. Microsc Res Tech 43:420
Grossfeld GD, Ginsberg DA, Stein JP et al (1997) Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89:219. https://doi.org/10.1093/jnci/89.3.219
Grujic M, Braga T, Lukinius A et al (2005) Serglycin deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J Biol Chem 280(39):33411–33418
Gubbiotti MA, Neill T, Iozzo RV (2017) A current view of perlecan in physiology and pathology: a mosaic of functions. Matrix Biol 57–58:285
Gudjonsson T, Villadsen R, Nielsen HL et al (2002) Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16:693. https://doi.org/10.1101/gad.952602
Haglund C, Ylätupa S, Mertaniemi P, Partanen P (1997) Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA. Br J Cancer 76:777. https://doi.org/10.1038/bjc.1997.461
Hansen K, Abrass CK (2003) Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF-induced mesangial cell migration. Kidney Int 64:110–118. https://doi.org/10.1046/j.1523-1755.2003.00039.x
Hasebe T, Sasaki S, Imoto S et al (2002) Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol 15:502. https://doi.org/10.1038/modpathol.3880555
Hassan M, Watari H, AbuAlmaaty A, Ohba Y, Sakuragi N (2014) Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2014:150845
Hawe JS, Theis FJ, Heinig M (2019) Inferring interaction networks from multi-omics data. Front Genet 10:535
Hayashi N, Miyata S, Yamada M et al (2005) Neuronal expression of the chondroitin sulfate proteoglycans receptor-type protein-tyrosine phosphatase β and phosphacan. Neuroscience 131:331. https://doi.org/10.1016/j.neuroscience.2004.11.017
He J, Zeng ZC, Xiang ZL, Yang P (2014) Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. World J Gastroenterol 20:3025–3032
Hempel N, How T, Cooper SJ et al (2008) Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta. Carcinogenesis 29:905–912. https://doi.org/10.1093/carcin/bgn049
Henningsson F, Hergeth S, Cortelius R, Abrink M, Pejler G (2006) A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J 273(21):4901–4912
Hewitt RE, Powe DG, Morrell K et al (1997) Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br J Cancer 75:221. https://doi.org/10.1038/bjc.1997.37
Hindermann W, Berndt A, Borsi L et al (1999) Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol 189:475. https://doi.org/10.1002/(SICI)1096-9896(199912)189:4<475::AID-PATH462>3.0.CO;2-V
Hoersch S, Andrade-Navarro MA (2010) Periostin shows increased evolutionary plasticity in its alternatively spliced region. BMC Evol Biol 10:30. https://doi.org/10.1186/1471-2148-10-30
Horiuchi K, Amizuka N, Takeshita S et al (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β. J Bone Miner Res 14:1239. https://doi.org/10.1359/jbmr.1999.14.7.1239
Horváth Z, Kovalszky I, Fullár A et al (2014) Decorin deficiency promotes hepatic carcinogenesis. Matrix Biol 35:194–205. https://doi.org/10.1016/j.matbio.2013.11.004
Hsiao Y-H, Lien H-C, Hwa H-L et al (2010) SPARC (osteonectin) in breast tumors of different histologic types and its role in the outcome of invasive ductal carcinoma. Breast J 16:305–308. https://doi.org/10.1111/j.1524-4741.2009.00899.x
Hsu SC, Volpert OV, Steck PA et al (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56(24):5684–5691
Hu L, Duan Y-T, Li J-F et al (2014) Biglycan enhances gastric cancer invasion by activating FAK signaling pathway. Oncotarget 5:1885–1896. https://doi.org/10.18632/oncotarget.1871
Huang S, Ingber DE (1999) The structural and mechanical complexity of cell-growth control. Nat Cell Biol 1(5):E131–E138
Hubbard NE, Chen QJ, Sickafoose LK et al (2013) Transgenic mammary epithelial osteopontin (spp1) expression induces proliferation and alveologenesis. Genes Cancer 4:201. https://doi.org/10.1177/1947601913496813
Hynes RO (1990) Fibronectins, 1st edn. Springer New York, New York
Ibrahim SA, Hassan H, Vilardo L et al (2013) Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One 8:e85737. https://doi.org/10.1371/journal.pone.0085737
Idowu MO, Kmieciak M, Dumur C et al (2012) CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol 43:364–373. https://doi.org/10.1016/j.humpath.2011.05.005
Ieda M, Tsuchihashi T, Ivey KN et al (2009) Cardiac fibroblasts regulate myocardial proliferation through B1 integrin signaling. Dev Cell 16:233. https://doi.org/10.1016/j.devcel.2008.12.007.Cardiac
Imano M, Satou T, Itoh T et al (2009) Immunohistochemical expression of osteopontin in gastric cancer. J Gastrointest Surg 13:1577–1582. https://doi.org/10.1007/s11605-009-0955-y
Ioachim E, Charchanti A, Briasoulis E et al (2002) Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 38:2362. https://doi.org/10.1016/S0959-8049(02)00210-1
Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609–652. https://doi.org/10.1146/annurev.biochem.67.1.609
Iozzo RV, Sanderson RD (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 15:1013–1031. https://doi.org/10.1111/j.1582-4934.2010.01236.x
Iozzo RV, Schaefer L (2015) Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol 42:11–55
Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274:4489. https://doi.org/10.1074/jbc.274.8.4489
Iruela-Arispe ML, Vernon RB, Wu H et al (1996) Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function. Dev Dyn 207:171. https://doi.org/10.1002/(SICI)1097-0177(199610)207:2<171::AID-AJA5>3.0.CO;2-E
Ishiba T, Nagahara M, Nakagawa T et al (2014) Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion. Sci Rep 4:7069. https://doi.org/10.1038/srep07069
Ishihara A, Tamaki H, Yoshida T, Sakakura T (1995) Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1(9):1035–1041
Jacobsen F, Kraft J, Schroeder C et al (2017) Up-regulation of biglycan is associated with poor prognosis and PTEN deletion in patients with prostate cancer. Neoplasia 19:707–715. https://doi.org/10.1016/j.neo.2017.06.003
Järveläinen H, Sainio A, Wight TN (2015) Pivotal role for decorin in angiogenesis. Matrix Biol 43:15
Jian J, Zheng Z, Zhang K et al (2013) Fibromodulin promoted in vitro and in vivo angiogenesis. Biochem Biophys Res Commun 436:530. https://doi.org/10.1016/j.bbrc.2013.06.005
Jiang Z, Jiang X, Chen S et al (2017) Anti-GPC3-CAR T cells suppress the growth of tumor cells in patient-derived xenografts of hepatocellular carcinoma. Front Immunol 7:690. https://doi.org/10.3389/fimmu.2016.00690
Jinnin M, Ihn H, Asano Y et al (2004) Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 23:1656. https://doi.org/10.1038/sj.onc.1207064
Johnson KG, Van Vactor D (2015) Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 83:1. https://doi.org/10.1152/physrev.00016.2002
Kadler KE, Hill A, Canty-Laird EG (2008) Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 20:495
Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422
Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537
Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820. https://doi.org/10.1038/nature04186
Kariya Y, Miyazaki K (2004) The basement membrane protein laminin-5 acts as a soluble cell motility factor. Exp Cell Res 297:508. https://doi.org/10.1016/j.yexcr.2004.03.044
Kauppila S, Stenbäck F, Risteli J et al (1998) Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol 186:262. https://doi.org/10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3
Kawataki T, Yamane T, Naganuma H et al (2007) Laminin isoforms and their integrin receptors in glioma cell migration and invasiveness: evidence for a role of α5-laminin(s) and α3β1 integrin. Exp Cell Res 313:3819. https://doi.org/10.1016/j.yexcr.2007.07.038
Kazerounian S, Yee KO, Lawler J (2008) Thrombospondins in cancer. Cell Mol Life Sci 65:700. https://doi.org/10.1016/j.pestbp.2011.02.012.Investigations
Kenny HA, Chiang CY, White EA et al (2014) Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest 124:4614. https://doi.org/10.1172/JCI74778
Khatun N, Arihiro K, Inai K (1992) Elastosis in breast—correlation with epithelial proliferation in benign disease and carcinomatous growth. Hiroshima J Med Sci 41(4):87–100
Kiani C, Chen L, Wu YJ et al (2002) Structure and function of aggrecan. Cell Res 12:19
Kibbey MC, Grant DS, Kleinman HK (1992) Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo matrigel model. J Natl Cancer Inst 84:1633. https://doi.org/10.1093/jnci/84.21.1633
Kii I, Nishiyama T, Li M et al (2010) Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 285:2028. https://doi.org/10.1074/jbc.M109.051961
Kikkawa Y, Umeda M, Miyazaki K (1994) Marked stimulation of cell adhesion and motility by ladsin, a laminin-like scatter factor. J Biochem 116:862. https://doi.org/10.1093/oxfordjournals.jbchem.a124608
Kikkawa Y, Hozumi K, Katagiri F et al (2013) Laminin-111-derived peptides and cancer. Cell Adh Migr 7:150
Kim CJ, Yoshioka N, Tambe Y et al (2005) Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int J Cancer 117:51. https://doi.org/10.1002/ijc.21120
Kim S, Takahashi H, Lin WW et al (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:102. https://doi.org/10.1038/nature07623
Kim BG, An HJ, Kang S et al (2011a) Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer. Am J Pathol 178:373. https://doi.org/10.1016/j.ajpath.2010.11.028
Kim JH, Ko JM, Lee I et al (2011b) A novel mutation of the decorin gene identified in a Korean family with congenital hereditary stromal dystrophy. Cornea 30:1473. https://doi.org/10.1097/ICO.0b013e3182137788
Kim BG, Gao MQ, Choi YP et al (2012) Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling. Breast Cancer Res 14:R88. https://doi.org/10.1186/bcr3203
Kischel P, Waltregny D, Dumont B et al (2010) Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Int J Cancer 126:640. https://doi.org/10.1002/ijc.24812
Kleinman HK, Koblinski J, Lee S, Engbring J (2001) Role of basement membrane in tumor growth and metastasis. Surg Oncol Clin N Am 10:329–338, ix
Klopffleisch K, Phan N, Augustin K, Bayne RS, Booker KS, Botella JR, Carpita NC, Carr T, Chen JG, Cooke TR, Frick-Cheng A, Friedman EJ, Fulk B, Hahn MG, Jiang K, Jorda L, Kruppe L, Liu C, Lorek J, McCann MC, Molina A, Moriyama EN, Mukhtar MS, Mudgil Y, Pattathil S, Schwarz J, Seta S, Tan M, Temp U, Trusov Y, Urano D, Welter B, Yang J, Panstruga R, Uhrig JF, Jones AM (2011) Arabidopsis G-protein interactome reveals connections to cell wall carbohydrates and morphogenesis. Mol Syst Biol 7:532. https://doi.org/10.1038/msb.2011.66
Knowles LM, Gurski LA, Engel C et al (2013) Integrin avb3 and fibronectin upregulate slug in cancer cells to promote clot invasion and metastasis. Cancer Res 73:6175. https://doi.org/10.1158/0008-5472.CAN-13-0602
Kolb M, Margetts PJ, Sime PJ, Gauldie J (2017) Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280:L1327. https://doi.org/10.1152/ajplung.2001.280.6.l1327
Kolset SO, Gallagher JT (1990) Proteoglycans in haemopoietic cells. Biochim Biophys Acta 1032:191–211
Kolset SO, Pejler G (2011) Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol 187:4927–4933
Kolset SO, Tveit H (2008) Serglycin–structure and biology. Cell Mol Life Sci 65:1073–1085
Kolset SO, Zernich L (2008) Serglycin and secretion in human monocytes. Glycoconj J 25:305–311
Korpetinou A, Skandalis SS, Moustakas A, Happonen KE, Tveit H, Prydz K et al (2013) Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells. PLoS One 8:e78157
Kortesmaa J, Yurchenco P, Tryggvason K (2000) Recombinant laminin-8 (alpha(4)beta(1)gamma(1)). Production, purification, and interactions with integrins. J Biol Chem 275:14853–14859. https://doi.org/10.1074/jbc.275.20.14853
Kruzynska-Frejtag A, Machnicki M, Rogers R et al (2001) Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 103:183. https://doi.org/10.1016/S0925-4773(01)00356-2
Kudo Y, Ogawa I, Kitajima S et al (2006) Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66:6928. https://doi.org/10.1158/0008-5472.CAN-05-4540
Kupprion C, Motamed K, Sage EH (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273:29635. https://doi.org/10.1074/jbc.273.45.29635
Kusuma N, Denoyer D, Eble JA et al (2012) Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis. Int J Cancer 130:555. https://doi.org/10.1002/ijc.26018
Kwon SY, Chae SW, Wilczynski SP et al (2012) Laminin 332 expression in breast carcinoma. Appl Immunohistochem Mol Morphol 20:159. https://doi.org/10.1097/PAI.0b013e3182329e8f
Leivonen M, Lundin J, Nordling S et al (2004) Prognostic value of syndecan-1 expression in breast cancer. Oncology 67:11–18. https://doi.org/10.1159/000080280
Lemire JM, Chan CK, Bressler S, Miller J, LeBaron RG, Wight TN (2007) Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J Cell Biochem 101:753–766
Lendorf ME, Manon-Jensen T, Kronqvist P et al (2011) Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma. J Histochem Cytochem 59:615. https://doi.org/10.1369/0022155411405057
Levental KR, Yu H, Kass L et al (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891. https://doi.org/10.1016/j.cell.2009.10.027
Leygue E, Snell L, Dotzlaw H et al (1998) Expression of lumican in human breast carcinoma. Cancer Res 58(7):1348–1352
Leygue E, Snell L, Dotzlaw H et al (2000) Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol 192:313. https://doi.org/10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.0.CO;2-B
Li SS, Ivanoff A, Bergström SE et al (2002) T lymphocyte expression of thrombospondin-1 and adhesion to extracellular matrix components. Eur J Immunol 32: 1069. https://doi.org/10.1002/1521-4141(200204)32:4<1069::AID-IMMU1069>3.0.CO;2-E
Li Q, Park PW, Wilson CL, Parks WC (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111: 635–646
Li G, Satyamoorthy K, Meier F et al (2003) Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 22:3162
Li XJ, Ong CK, Cao Y, Xiang YQ, Shao JY, Ooi A et al (2011) Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Res 71:3162–3172
Lian J, Dai X, Li X, He F (2006) Identification of an active site on the laminin α4 chain globular domain that binds to αvβ3 integrin and promotes angiogenesis. Biochem Biophys Res Commun 347:248. https://doi.org/10.1016/j.bbrc.2006.06.069
Libby RT, Champliaud M-F, Claudepierre T et al (2018) Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J Neurosci 20:6517. https://doi.org/10.1523/jneurosci.20-17-06517.2000
Lin F, Li Y, Cao J et al (2011) Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells. Mol Biol Rep 38:5205. https://doi.org/10.1007/s11033-010-0671-4
Liu BP, Cafferty WBJ, Budel SO, Strittmatter SM (2006) Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci 361:1593
Liu TJ, LaFortune T, Honda T, Ohmori O, Hatakeyama S, Meyer T, Jackson D, de Groot J, Yung WK (2007) Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol Cancer Ther 6(4):1357–1367
Liu AY, Zheng H, Ouyang G (2014) Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol 37:150
Liu Y, Beyer A, Aebersold R (2016) On the dependency of cellular protein levels on mRNA abundance. Cell 165(3):535–550
Lochter A, Bissell MJ (1995) Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol 6:165. https://doi.org/10.1006/scbi.1995.0017
Lou X, Han X, Jin C et al (2013) SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention. OMICS 17:510. https://doi.org/10.1089/omi.2013.0058
Lu R, Wu C, Guo L et al (2012) The role of brevican in glioma: promoting tumor cell motility in vitro and in vivo. BMC Cancer 12:607. https://doi.org/10.1186/1471-2407-12-607
Lu H, Niu F, Liu F et al (2017) Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma. Cancer Med 6:1181–1191. https://doi.org/10.1002/cam4.1064
Lv X, Fang C, Yin R et al (2017) Agrin para-secreted by PDGF-activated human hepatic stellate cells promotes hepatocarcinogenesis in vitro and in vivo. Oncotarget 8:105340–105355. https://doi.org/10.18632/oncotarget.22186
Määttä M, Virtanen I, Burgeson R, Autio-Harmainen H (2001) Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the α1 chain of laminin shows a selected expression pattern in human carcinomas. J Histochem Cytochem 49:711. https://doi.org/10.1177/002215540104900605
Macias H, Hinck L (2012) Mammary gland development. Wiley Interdiscip Rev Dev Biol 1(4):533–557
Maeda T, Alexander CM, Friedl A (2004) Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 64:612–621
Malanchi I, Santamaria-Martínez A, Susanto E et al (2012) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481:85. https://doi.org/10.1038/nature10694
Malinda KM, Kleinman HK (1996) The laminins. Int J Biochem Cell Biol 28:957–959
Malinda KM, Nomizu M, Chung M et al (1999) Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J 13:53
Mao Y, Schwarzbauer JE (2005) Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24:389
Marotta LLC, Almendro V, Marusyk A et al (2011) The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors. J Clin Invest 121:2723–2735. https://doi.org/10.1172/JCI44745
Martin-Manso G, Calzada MJ, Chuman Y et al (2011) sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. Arch Biochem Biophys 509:147–156. https://doi.org/10.1016/j.abb.2011.03.004
Matsuda K, Maruyama H, Guo F et al (2001) Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61:5562–5569
Matsuura H, Momota Y, Murata K et al (2004) Localization of the laminin α4 chain in the skin and identification of a heparin-dependent cell adhesion site within the laminin α4 chain C-terminal LG4 module. J Invest Dermatol 122:614. https://doi.org/10.1111/j.0022-202X.2004.22325.x
Matzuk MM, Finegold MJ, Su JGJ et al (1992) α-Lnhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313. https://doi.org/10.1038/360313a0
Maumus M, Manferdini C, Toupet K et al (2017) Thrombospondin-1 partly mediates the cartilage protective effect of adipose-derived mesenchymal stem cells in osteoarthritis. Front Immunol 8:1638. https://doi.org/10.3389/fimmu.2017.01638
MAURER P, MAYER U, BRUCH M et al (1992) High-affinity and low-affinity calcium binding and stability of the multidomain extracellular 40-kDa basement membrane glycoprotein (BM-40/SPARC/osteonectin). Eur J Biochem 205:233. https://doi.org/10.1111/j.1432-1033.1992.tb16773.x
Maurer P, Hohenadl C, Hohenester E et al (1995) The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J Mol Biol 253:347–357. https://doi.org/10.1006/jmbi.1995.0557
Mayer U, Aumailley M, Mann K et al (1991) Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. Eur J Biochem 198:141. https://doi.org/10.1111/j.1432-1033.1991.tb15996.x
McAllister SS, Gifford AM, Greiner AL et al (2008) Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 133:994. https://doi.org/10.1016/j.cell.2008.04.045
McIntosh J, Dennison G, Holly JMP et al (2010) IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin. J Biol Chem 285:38788. https://doi.org/10.1074/jbc.M110.177311
Menon PM, Gutierrez JA, Rempel SA (2000) A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin. Int J Oncol 17(4):683–693
Merle B, Garnero P (2012) The multiple facets of periostin in bone metabolism. Osteoporos Int 23:1199
Mierke CT, Frey B, Fellner M et al (2011) Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces. J Cell Sci 124:369. https://doi.org/10.1242/jcs.071985
Miner JH, Patton BL, Lentz SI et al (1997) The laminin α chains: expression, developmental transitions, and chromosomal locations of α1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel α3 isoform. J Cell Biol 137:685
Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518. https://doi.org/10.1038/nature03799
Mishra NK, Shukla M (2014) Application of computational proteomics and lipidomics in drug discovery. J Theor Comput Sci 1:1. https://doi.org/10.4172/2376-130X.1000105
Mitra AK, Sawada K, Tiwari P et al (2011) Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30:1566–1576. https://doi.org/10.1038/onc.2010.532
Morcavallo A, Buraschi S, Xu SQ et al (2014) Decorin differentially modulates the activity of insulin receptor isoform A ligands. Matrix Biol 35:82. https://doi.org/10.1016/j.matbio.2013.12.010
Morrione A, Neill T, Iozzo RV (2013) Dichotomy of decorin activity on the insulin-like growth factor-I system. FEBS J 280:2138
Moscatello DK, Santra M, Mann DM et al (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 101:406. https://doi.org/10.1172/JCI846
Mukhopadhyay A, Nikopoulos K, Maugeri A et al (2006) Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants. Invest Opthalmol Vis Sci 47:3565. https://doi.org/10.1167/iovs.06-0141
Murphy-Ullrich JE (2001) The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 107:785
Murphy-Ullrich JE, Sage EH (2014) Revisiting the matricellular concept. Matrix Biol 37:1. https://doi.org/10.1016/j.matbio.2014.07.005
Murphy-Ullrich JE, Lightner VA, Aukhil I et al (1991) Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol 115:1127. https://doi.org/10.1083/jcb.115.4.1127
Myllyharju J, Kivirikko KI (2001) Collagens and collagen-related diseases. Ann Med 33:7
Mythreye K, Blobe GC (2009) The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci 106:8221. https://doi.org/10.1073/pnas.0812879106
Nagaharu K, Zhang X, Yoshida T et al (2011) Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol 178:754. https://doi.org/10.1016/j.ajpath.2010.10.015
Nam JM, Onodera Y, Bissell MJ, Park CC (2010) Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin α5β1 and fibronectin. Cancer Res 70:5238. https://doi.org/10.1158/0008-5472.CAN-09-2319
Neill T, Painter H, Buraschi S et al (2012) Decorin antagonizes the angiogenic network: concurrent inhibition of met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and tiMP3. J Biol Chem 287:5492. https://doi.org/10.1074/jbc.M111.283499
Neill T, Jones HR, Crane-Smith Z et al (2013) Decorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1. FEBS J 280:2353–2368. https://doi.org/10.1111/febs.12148
Neill T, Schaefer L, Iozzo RV (2014) Instructive roles of extracellular matrix on autophagy. Am J Pathol 184:2146–2153. https://doi.org/10.1016/j.ajpath.2014.05.010
Nemir M, Bhattacharyya D, Li X et al (2000) Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency. J Biol Chem 275:969. https://doi.org/10.1074/jbc.275.2.969
Nguyen BP, Ryan MC, Gil SG, Carter WG (2000) Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr Opin Cell Biol 12:554
Nicolosi PA, Dallatomasina A, Perris R (2015) Theranostic impact of NG2/CSPG4 proteoglycan in cancer. Theranostics 5:530–544. https://doi.org/10.7150/thno.10824
Niemann CU, Cowland JB, Klausen P et al (2004) Localization of serglycin in human neutrophil granulocytes and their precursors. J Leukoc Biol 76(2):406–415
Nikitovic D, Berdiaki A, Zafiropoulos A et al (2008) Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells. FEBS J 275:350. https://doi.org/10.1111/j.1742-4658.2007.06205.x
Nikitovic D, Chalkiadaki G, Berdiaki A et al (2011) Lumican regulates osteosarcoma cell adhesion by modulating TGFβ2 activity. Int J Biochem Cell Biol 43:928. https://doi.org/10.1016/j.biocel.2011.03.008
Nikitovic D, Papoutsidakis A, Karamanos NK, Tzanakakis GN (2014) Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response. Matrix Biol 35:206. https://doi.org/10.1016/j.matbio.2013.09.003
Nikolopoulos SN, Blaikie P, Yoshioka T et al (2005) Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol Cell Biol 25:6090. https://doi.org/10.1128/mcb.25.14.6090-6102.2005
Nikolovska K, Renke JK, Jungmann O et al (2014) A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function. Matrix Biol 35:91–102. https://doi.org/10.1016/j.matbio.2014.01.003
Nischt R, Pottgiesser J, Krieg T et al (1991) Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur J Biochem 200:529. https://doi.org/10.1111/j.1432-1033.1991.tb16214.x
Noel A, Kebers F, Maquoi E, Foidart JM (1999) Cell-cell and cell-matrix interactions during breast cancer progression. Curr Top Pathol 93:183–193
Norris RA, Moreno-Rodriguez RA, Sugi Y et al (2008) Periostin regulates atrioventricular valve maturation. Dev Biol 316:200. https://doi.org/10.1016/j.ydbio.2008.01.003
Nucera C, Porrello A, Antonello ZA et al (2010) B-RafV600E and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci 107:10649. https://doi.org/10.1073/pnas.1004934107
O’Connell JT, Sugimoto H, Cooke VG et al (2011) VEGF-A and tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci 108:16002. https://doi.org/10.1073/pnas.1109493108
Oates AJ, Barraclough R, Rudland PS (1996) The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13(1):97–104
Oda G, Sato T, Ishikawa T et al (2012) Significance of stromal decorin expression during the progression of breast cancer. Oncol Rep 28:2003
Oikawa Y, Hansson J, Sasaki T et al (2011) Melanoma cells produce multiple laminin isoforms and strongly migrate on α5 laminin(s) via several integrin receptors. Exp Cell Res 317:1119. https://doi.org/10.1016/j.yexcr.2010.12.019
Oldberg A, Kalamajski S, Salnikov AV et al (2007) Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma. Proc Natl Acad Sci 104:13966. https://doi.org/10.1073/pnas.0702014104
Oliver CJ, Terry-Lorenzo RT, Elliott E, Bloomer WA, Li S, Brautigan DL, Colbran RJ, Shenolikar S (2002) Targeting protein phosphatase 1 (PP1) to the actin cytoskeleton: the neurabin I/PP1 complex regulates cell morphology. Mol Cell Biol 22(13):4690–4701
Ontsuka K, Shiraishi H, Arima K et al (2012) Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp Dermatol 21:331. https://doi.org/10.1111/j.1600-0625.2012.01454.x
Orend G, Chiquet-Ehrismann R (2006) Tenascin-C induced signaling in cancer. Cancer Lett 244:143
Oskarsson T (2013) Extracellular matrix components in breast cancer progression and metastasis. Breast 22:S66. https://doi.org/10.1016/j.breast.2013.07.012
Oskarsson T, Acharyya S, Zhang XHF et al (2011) Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 17:867. https://doi.org/10.1038/nm.2379
Palm W, Thompson CB (2017) Nutrient acquisition strategies of mammalian cells. Nature 546(7657):234–242
Pantazaka E, Papadimitriou E (2014) Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migration. Biochim Biophys Acta 1840:2643
Park SH, Park S, Kim DY et al (2015) Isolation and characterization of a monobody with a fibronectin domain III scaffold that specifically binds EphA2. PLoS One 10:e0132976. https://doi.org/10.1371/journal.pone.0132976
Paszek MJ, Zahir N, Johnson KR et al (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8:241–254. https://doi.org/10.1016/j.ccr.2005.08.010
Patarroyo M, Tryggvason K, Virtanen I (2002) Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 12:197. https://doi.org/10.1016/S1044-579X(02)00023-8
Patthy L, Nikolics K (1994) Agrin-like proteins of the neuromuscular junction. Neurochem Int 24(4):301–316
Pedraza C, Geberhiwot T, Ingerpuu S et al (2000) Monocytic cells synthesize, adhere to, and migrate on laminin-8 (alpha 4 beta 1 gamma 1). J Immunol 165:5831–5838. https://doi.org/10.4049/jimmunol.165.10.5831
Pejler G, Abrink M, Wernersson S (2009) Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases. Biofactors 35:61–68
Petäjäniemi N, Korhonen M, Kortesmaa J et al (2002) Localization of laminin α4-chain in developing and adult human tissues. J Histochem Cytochem 50:1113. https://doi.org/10.1177/002215540205000813
Peters MG, Farías E, Colombo L et al (2003) Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res Treat 80:221–232. https://doi.org/10.1023/A:1024549729256
Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ (2006) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci 89:9064. https://doi.org/10.1073/pnas.89.19.9064
Peterson SB, Liu J (2013) Multi-faceted substrate specificity of heparanase. Matrix Biol 32:223
Petrovici K, Graf M, Hecht K et al (2010) Use of NG2 (7.1) in AML as a tumor marker and its association with a poor prognosis. Cancer Genomics Proteomics 7(4):173–180
Phillips GR, Crossin KL, Krushel LA (1998) Domains of tenascin involved in glioma migration. J Cell Sci 111(Pt 8):1095–1104
Pietraszek K, Chatron-Colliet A, Brézillon S et al (2014) Lumican: a new inhibitor of matrix metalloproteinase-14 activity. FEBS Lett 588:4319–4324. https://doi.org/10.1016/j.febslet.2014.09.040
Poltavets V, Kochetkova M, Pitson SM, Samuel MS (2018) The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Front Oncol 8:431. https://doi.org/10.3389/fonc.2018.00431
Pottgiesser J, Maurer P, Mayer U et al (1994) Changes in calcium and collagen iv binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). J Mol Biol 238:563. https://doi.org/10.1006/jmbi.1994.1315
Provenzano PP, Eliceiri KW, Campbell JM et al (2006) Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 4:38. https://doi.org/10.1186/1741-7015-4-38
Provenzano PP, Inman DR, Eliceiri KW et al (2008) Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys J 95:5374. https://doi.org/10.1529/biophysj.108.133116
Provenzano PP, Inman DR, Eliceiri KW, Keely PJ (2009) Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK–ERK linkage. Oncogene 28:4326–4343. https://doi.org/10.1038/onc.2009.299
Puglisi F, Puppin C, Pegolo E et al (2008) Expression of periostin in human breast cancer. J Clin Pathol 61:494. https://doi.org/10.1136/jcp.2007.052506
Purushothaman A, Toole BP (2014) Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization. J Biol Chem 289:5499–5509
Purushothaman A, Uyama T, Kobayashi F et al (2010) Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 115:2449. https://doi.org/10.1182/blood-2009-07-234757
Qian P, Zuo Z, Wu Z et al (2011) Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res 71:6463. https://doi.org/10.1158/0008-5472.CAN-11-1322
Rahmani M, Wong BW, Ang L et al (2006) Versican: signaling to transcriptional control pathways. This paper is one of a selection of papers published in this Special Issue, entitled Young Investigator’s Forum. Can J Physiol Pharmacol 84:77–92. https://doi.org/10.1139/y05-154
Raimondi C, Gradilone A, Naso G et al (2011) Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat 130:449. https://doi.org/10.1007/s10549-011-1373-x
Ramani VC, Purushothaman A, Stewart MD et al (2013) The heparanase/syndecan-1 axis in cancer: mechanisms and therapies. FEBS J 280:2294–2306. https://doi.org/10.1111/febs.12168
Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49. https://doi.org/10.1038/ng1060
Rapraeger AC (2013) Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis. FEBS J 280:2207–2215. https://doi.org/10.1111/febs.12160
Ratajczak-Wielgomas K, Grzegrzolka J, Piotrowska A et al (2016) Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma. Oncol Rep 36:2745–2754. https://doi.org/10.3892/or.2016.5095
Ratcliffe CF, Qu Y, McCormick KA et al (2000) A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase β. Nat Neurosci 3:437. https://doi.org/10.1038/74805
Reed CC, Waterhouse A, Kirby S et al (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24:1104–1110. https://doi.org/10.1038/sj.onc.1208329
Ribeiro N, Sousa SR, Brekken RA, Monteiro FJ (2014) Role of sparc in bone remodeling and cancer-related bone metastasis. J Cell Biochem 115:17. https://doi.org/10.1002/jcb.24649
Ricciardelli C, Brooks JH, Suwiwat S et al (2002) Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res 8(4):1054–1060
Rittling SR, Novick KE (1997) Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ 8(10):1061–1069
Rivera Z, Ferrone S, Wang X et al (2012) CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma. Clin Cancer Res 18:5352. https://doi.org/10.1158/1078-0432.CCR-12-0628
Rosenblatt S, Bassuk JA, Alpers CE et al (1997) Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem J 324:311–319. https://doi.org/10.1042/bj3240311
Ross JB, Huh D, Noble LB, Tavazoie SF (2015) Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer. Nat Cell Biol 17:651. https://doi.org/10.1038/ncb3148
Rousselle P, Aumailley M (1994) Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors. J Cell Biol 125:205. https://doi.org/10.1083/jcb.125.1.205
Rousselle P, Lunstrum GP, Keene DR, Burgeson RE (1991) Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 114:567. https://doi.org/10.1083/jcb.114.3.567
Ruan K, Bao S, Ouyang G (2009) The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 66:2219
Sage H, Johnson C, Bornstein P (1984) Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J Biol Chem 259(6):3993–4007
Sage H, Vernon RB, Decker J et al (1989) Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem 37:819. https://doi.org/10.1177/37.6.2723400
Salesse S, Odoul L, Chazée L et al (2018) Elastin molecular aging promotes MDA-MB-231 breast cancer cell invasiveness. FEBS Open Bio 8:1395. https://doi.org/10.1002/2211-5463.12455
Sangaletti S, Colombo MP (2008) Matricellular proteins at the crossroad of inflammation and cancer. Cancer Lett 267:245
Santra M, Reed CC, Iozzo RV (2002) Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem 277:35671. https://doi.org/10.1074/jbc.M205317200
Sasaki T, Hohenester E, Göhring W, Timpl R (1998) Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J 17:1625. https://doi.org/10.1093/emboj/17.6.1625
Sato S, Tang YJ, Wei Q et al (2016) Mesenchymal tumors can derive from Ng2/Cspg4-expressing pericytes with β-catenin modulating the neoplastic phenotype. Cell Rep 16:917–927. https://doi.org/10.1016/j.celrep.2016.06.058
Schenk S, Chiquet-Ehrismann R, Battegay EJ (1999) The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Mol Biol Cell 10:2933. https://doi.org/10.1091/mbc.10.9.2933
Schick BP, Gradowski JF, San Antonio JD (2001) Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells. Blood 97:449–458
Schick BP, Ho HC, Brodbeck KC, Wrigley CW, Klimas J (2003) Serglycin proteoglycan expression and synthesis in embryonic stem cells. Biochim Biophys Acta 1593:259–267
Seo BR, Bhardwaj P, Choi S et al (2015) Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med 7:301ra130. https://doi.org/10.1126/scitranslmed.3010467
Shao R, Bao S, Bai X et al (2004) Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24:3992. https://doi.org/10.1128/mcb.24.9.3992-4003.2004
Sharma B, Ramus MD, Kirkwood CT et al (2013) Lumican exhibits anti-angiogenic activity in a context specific manner. Cancer Microenviron 6:263. https://doi.org/10.1007/s12307-013-0134-2
Shevde LA, Samant RS (2014) Role of osteopontin in the pathophysiology of cancer. Matrix Biol 37:131
Shevde LA, Samant RS, Paik JC et al (2006) Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis 23:123. https://doi.org/10.1007/s10585-006-9013-2
Sifaki M, Assouti M, Nikitovic D et al (2006) Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes. IUBMB Life 58:606–610. https://doi.org/10.1080/15216540600951605
Singhai H, Bautista DS, Tonkin KS et al (1997) Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 3(4):605–611
Sjöberg A, Önnerfjord P, Mörgelin M et al (2005) The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem 280:32301. https://doi.org/10.1074/jbc.M504828200
Skandalis A, Uribe E (2004) A survey of splice variants of the human hypoxanthine phosphoribosyl transferase and DNA polymerase beta genes: products of alternative or aberrant splicing? Nucleic Acids Res 32:6557. https://doi.org/10.1093/nar/gkh967
Skandalis SS, Theocharis AD, Vynios DH et al (2006) Cartilage aggrecan undergoes significant compositional and structural alterations during laryngeal cancer. Biochim Biophys Acta 1760:1046. https://doi.org/10.1016/j.bbagen.2006.02.007
Skandalis SS, Afratis N, Smirlaki G et al (2014) Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans. Matrix Biol 35:182–193. https://doi.org/10.1016/j.matbio.2013.09.002
Slavik J, Clancy R, Yarina W et al (2017) Cell surface proteoglycans as potential targets for immunotherapy in women’s cancer. J Gynecol Womens Health 7(2):1–3. https://doi.org/10.19080/JGWH.2017.07.555709
Snider P, Hinton RB, Moreno-Rodriguez RA et al (2008) Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res 102:752. https://doi.org/10.1161/CIRCRESAHA.107.159517
Sollberg S, Peltonen J, Uitto J (1992) Differential expression of laminin isoforms and β4 integrin epitopes in the basement membrane zone of normal human skin and basal cell carcinomas. J Invest Dermatol 98:864. https://doi.org/10.1111/1523-1747.ep12457080
Soltermann A, Tischler V, Arbogast S et al (2008) Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14:7430. https://doi.org/10.1158/1078-0432.CCR-08-0935
Song HH, Filmus J (2002) The role of glypicans in mammalian development. Biochim Biophys Acta 1573:241–246
Soria-Valles C, Gutiérrez-Fernández A, Guiu M et al (2014) The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene 33:3054–3063. https://doi.org/10.1038/onc.2013.267
Sottile J (2002) Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 13:3546. https://doi.org/10.1091/mbc.e02-01-0048
Souiai O, Becker E, Prieto C, Benkahla A, De las Rivas J, Brun C (2011) Functional integrative levels in the human interactome recapitulate organ organization. PLoS One 6(7):e22051. https://doi.org/10.1371/journal.pone.0022051
Sriram R, Lo V, Pryce B et al (2015) Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity. Breast Cancer Res 17:7. https://doi.org/10.1186/s13058-014-0513-8
Standal T, Borset M, Sundan A (2004) Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 26(3):179–184
Stanley MJ, Stanley MW, Sanderson RD, Zera R (1999) Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 112:377–383
Stepp MA, Gibson HE, Gala PH, Iglesia DD, Pajoohesh-Ganji A, Pal-Ghosh S, Brown M, Aquino C, Schwartz AM, Goldberger O, Hinkes MT, Bernfield M (2002) Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J Cell Sci 115:4517–4531
Sternlicht MD, Lochter A, Sympson CJ et al (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137–146. https://doi.org/10.1016/s0092-8674(00)81009-0
Stover DG, Bierie B, Moses HL (2007) A delicate balance: TGF-β and the tumor microenvironment. J Cell Biochem 101:851
Streuli CH, Edwards GM (1998) Control of normal mammary epithelial phenotype by integrins. J Mammary Gland Biol Neoplasia 3:151. https://doi.org/10.1023/A:1018742822565
Streuli CH, Schmidhauser C, Bailey N et al (1995) Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol 129:591. https://doi.org/10.1083/jcb.129.3.591
Stylianou M, Skandalis SS, Papadas TA et al (2008) Stage-related decorin and versican expression in human laryngeal cancer. Anticancer Res 28(1A):245–251
Su V, Lau AF (2014) Connexins: mechanisms regulating protein levels and intercellular communication. FEBS Lett 588(8):1212–1220
Su Z, Kishida S, Tsubota S et al (2017) Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes. Oncotarget 8:106296. https://doi.org/10.18632/oncotarget.22435
Suhovskih AV, Mostovich LA, Kunin IS et al (2013) Proteoglycan expression in normal human prostate tissue and prostate cancer. ISRN Oncol 2013:680136. https://doi.org/10.1155/2013/680136
Sun L, Chen C (1997) Expression of transforming growth factor β type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. J Biol Chem 272:25367. https://doi.org/10.1074/jbc.272.40.25367
Svendsen A, Verhoeff JJC, Immervoll H et al (2011) Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol 122:495–510. https://doi.org/10.1007/s00401-011-0867-2
Szatmári T, Ötvös R, Hjerpe A, Dobra K (2015) Syndecan-1 in cancer: implications for cell signaling, differentiation, and prognostication. Dis Markers 2015:796052
Talts JF, Sasaki T, Miosge N et al (2000) Structural and functional analysis of the recombinant G domain of the laminin α4 chain and its proteolytic processing in tissues. J Biol Chem 275:35192. https://doi.org/10.1074/jbc.M003261200
Tavazoie SF, Alarcón C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147. https://doi.org/10.1038/nature06487
Termine JD, Kleinman HK, Whitson SW et al (1981) Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26:99. https://doi.org/10.1016/0092-8674(81)90037-4
Thalmann GN, Sikes RA, Devoll RE et al (1999) Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5:2271–2277
Thayer JM, Giachelli CM, Mirkes PE, Schwartz SM (1995) Expression of osteopontin in the head process late in gastrulation in the rat. J Exp Zool 272:240. https://doi.org/10.1002/jez.1402720309
Theocharis AD (2008) Versican in health and disease. Connect Tissue Res 49:230. https://doi.org/10.1080/03008200802147571
Theocharis AD, Karamanos NK (2019) Proteoglycans remodeling in cancer: underlying molecular mechanisms. Matrix Biol 75-76:220
Theocharis AD, Seidel C, Borset M, Dobra K, Baykov V, Labropoulou V, Kanakis I, Dalas E, Karamanos NK, Sundan A, Hjerpe A (2006) Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J Biol Chem 281:35116–35128
Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277:3904
Theocharis A, Gialeli C, Hascall V, Karamanos NK (2012) 1.1 Extracellular matrix: a functional scaffold. In: Extracellular matrix: pathobiology and signaling, 1st edn. Walter de Gruyter, Berlin
Theocharis AD, Gialeli C, Bouris P et al (2014) Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. FEBS J 281:5023
Theocharis AD, Skandalis SS, Neill T et al (2015) Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta 1855:276
Thompson CA, Purushothaman A, Ramani VC et al (2013) Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J Biol Chem 288:10093. https://doi.org/10.1074/jbc.C112.444562
Tian B, Zhang Y, Zhang J (2014) Periostin is a new potential prognostic biomarker for glioma. Tumor Biol 35:5877. https://doi.org/10.1007/s13277-014-1778-3
Tokunaga T, Nakamura M, Oshika Y et al (1999) Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br J Cancer 79:354. https://doi.org/10.1038/sj.bjc.6690056
Torbenson M, Wang J, Choti M et al (2002) Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod Pathol 15:826. https://doi.org/10.1097/01.MP.0000024257.83046.7C
Toupance S, Brassart B, Rabenoelina F et al (2012) Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA. Clin Exp Metastasis 29:511. https://doi.org/10.1007/s10585-012-9467-3
Toyama-Sorimachi N, Kitamura F, Habuchi H et al (1997) Widespread expression of chondroitin sulfate type serglycins with CD44 binding ability in hematopoietic cells. J Biol Chem 272(42):26714–26719
Tremble P, Chiquet-Ehrismann R, Werb Z (1994) The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 5:439. https://doi.org/10.1091/mbc.5.4.439
Troup S, Njue C, Kliewer EV et al (2003) Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9:207–214
Tse JM, Cheng G, Tyrrell JA et al (2012) Mechanical compression drives cancer cells toward invasive phenotype. Proc Natl Acad Sci U S A 109:911. https://doi.org/10.1073/pnas.1118910109
Tsonis AI, Afratis N, Gialeli C et al (2013) Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells. FEBS J 280:2248. https://doi.org/10.1111/febs.12162
Tuck AB, Chambers AF (2001) The role of osteopontin in breast cancer: clinical and experimental studies. J Mammary Gland Biol Neoplasia 6:419
Tuck AB, O’Malley FP, Singhal H et al (1997) Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch Pathol Lab Med 121(6):578–584
Tuck AB, O’Malley FP, Singhal H et al (1998) Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 79:502. https://doi.org/10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3
Tuck AB, Chambers AF, Allan AL (2007) Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. J Cell Biochem 102:859
Tucker RP, Hagios C, Chiquet-Ehrismann R et al (1999) Thrombospondin-1 and neural crest cell migration. Dev Dyn 214:312–322. https://doi.org/10.1002/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A
Tuxhorn JA, Ayala GE, Smith MJ et al (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8(9):2912–2923
Tyan SW, Hsu CH, Peng KL, Chen CC, Kuo WH, Lee EY et al (2012) Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change. PLoS One 7:e35128
Vainionpää N, Bützow R, Hukkanen M et al (2007) Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas. Cell Tissue Res 328:317. https://doi.org/10.1007/s00441-006-0366-2
Vanhoutte D, Schips TG, Kwong JQ et al (2016) Thrombospondin expression in myofibers stabilizes muscle membranes. Elife 5:pii: e17589. https://doi.org/10.7554/elife.17589
Vesentini S, Redaelli A, Montevecchi FM (2005) Estimation of the binding force of the collagen molecule-decorin core protein complex in collagen fibril. J Biomech 38:433. https://doi.org/10.1016/j.jbiomech.2004.04.032
Vlodavsky I, Elkin M, Ilan N (2011) Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications. Rambam Maimonides Med J 2:e0019. https://doi.org/10.5041/rmmj.10019
Vogel WF, Aszodi A, Alves F, Pawson T (2002) Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 21:2906. https://doi.org/10.1128/mcb.21.8.2906-2917.2001
von Holst A (2008) Tenascin C in stem cell niches: redundant, permissive or instructive? Cells Tissues Organs 188:170–177. https://doi.org/10.1159/000112848
Wang H, Fu W, Im JH et al (2004) Tumor cell α3β1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 164:935. https://doi.org/10.1083/jcb.200309112
Wang X, Wang Y, Yu L et al (2010) CSPG4 in cancer: multiple roles. Curr Mol Med 10:419–429
Wang J, Svendsen A, Kmiecik J et al (2011) Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One 6:e23062. https://doi.org/10.1371/journal.pone.0023062
Wang W, Li P, Li W et al (2017) Osteopontin activates mesenchymal stem cells to repair skin wound. PLoS One 12:e0185346. https://doi.org/10.1371/journal.pone.0185346
Wani N, Raza K (2019) Integrative approaches to reconstruct regulatory networks from multi-omics data: A review of state-of-the-art methods. Comput Biol Chem 83:107120. https://doi.org/10.1016/j.compbiolchem.2019.107120
Warawdekar UM, Zingde SM, Iyer KSN et al (2006) Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients. Clin Chim Acta 372:83. https://doi.org/10.1016/j.cca.2006.03.023
Watkins G, Douglas-Jones A, Bryce R et al (2005) Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes. Prostaglandins Leukot Essent Fat Acids 72:267. https://doi.org/10.1016/j.plefa.2004.12.003
Weber GF, Lett GS, Haubein NC (2010) Osteopontin is a marker for cancer aggressiveness and patient survival. Br J Cancer 103:861. https://doi.org/10.1038/sj.bjc.6605834
Wei W, Beihua K, Qifeng Y, Xun Q (2010) Hepatocyte growth factor enhances ovarian cancer cell invasion through downregulation of thrombospondin-1. Cancer Biol Ther 9:79. https://doi.org/10.4161/cbt.9.2.10280
Wei PL, Kuo LJ, Huang MT et al (2011) Nicotine enhances colon cancer cell migration by induction of fibronectin. Ann Surg Oncol 18:1782. https://doi.org/10.1245/s10434-010-1504-3
Whitaker-Menezes D, Schechter NM, Murphy GF (1995) Serine proteinases are regionally segregated within mast cell granules. Lab Invest 72(1):34–41
Wight TN, Kang I, Merrilees MJ (2014a) Versican and the control of inflammation. Matrix Biol 35:152. https://doi.org/10.1016/j.matbio.2014.01.015
Wight TN, Kinsella MG, Evanko SP et al (2014b) Versican and the regulation of cell phenotype in disease. Biochim Biophys Acta 1840:2441
Wilson BS, Imai K, Natali PG, Ferrone S (1981) Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 28:293–300
Wilson KE, Langdon SP, Lessells AM, Miller WR (1996) Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br J Cancer 74:999. https://doi.org/10.1038/bjc.1996.480
Winberg JO, Kolset SO, Berg E et al (2000) Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 304(4):669–680
Witkiewicz AK, Freydin B, Chervoneva I et al (2010) Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence. Cancer Biol Ther 10:391. https://doi.org/10.4161/cbt.10.4.12449
Wondimu Z, Geberhiwot T, Ingerpuu S et al (2004) An endothelial laminin isoform, laminin 8 (α4β1γ1), is secreted by blood neutrophils, promotes neutrophil migration and extravasation, and protects neutrophils from apoptosis. Blood 104:1859. https://doi.org/10.1182/blood-2004-01-0396
Wong GS, Rustgi AK (2013) Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br J Cancer 108:755
Woods A, Couchman JR (2013) Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5:183. https://doi.org/10.1091/mbc.5.2.183
Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, Abrink M et al (2008) Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice. Blood 111:3458–3467
Wyckoff JB, Wang Y, Lin EY et al (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67:2649. https://doi.org/10.1158/0008-5472.CAN-06-1823
Xian X, Gopal S, Couchman JR (2010) Syndecans as receptors and organizers of the extracellular matrix. Cell Tissue Res 339:31–46. https://doi.org/10.1007/s00441-009-0829-3
Xiang Y-Y, Ladeda V, Filmus J (2001) Glypican-3 expression is silenced in human breast cancer. Oncogene 20:7408–7412. https://doi.org/10.1038/sj.onc.1204925
Xiong WC, Mei L (2017) Agrin to YAP in cancer and neuromuscular junctions. Trends Cancer 3:247
Xu D, Esko JD (2014) Demystifying heparan sulfate-protein interactions. Annu Rev Biochem 83:129–157. https://doi.org/10.1146/annurev-biochem-060713-035314
Xu T, Bianco P, Fisher LW et al (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:78–82. https://doi.org/10.1038/1746
Xu D, Xu H, Ren Y et al (2012) Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One 7:e46670. https://doi.org/10.1371/journal.pone.0046670
Yamada KM, Clark RAF (1988) Provisional matrix. In: The molecular and cellular biology of wound repair. Plenum Press, New York
Yamaguchi Y, Mann DM, Ruoslahti E (1990) Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281. https://doi.org/10.1038/346281a0
Yamazaki D, Kurisu S, Takenawa T (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci 96(7):379–386
Yang Y, Yaccoby S, Liu W et al (2002) Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100:610–617
Yee AJ, Akens M, Yang BL et al (2007) The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 9:R47. https://doi.org/10.1186/bcr1751
Yee KO, Connolly CM, Duquette M et al (2009) The effect of thrombospondin-1 on breast cancer metastasis. Breast Cancer Res Treat 114:85. https://doi.org/10.1007/s10549-008-9992-6
Ylätupa S, Haglund C, Mertaniemi P et al (1995) Cellular fibronectin in serum and plasma: a potential new tumour marker? Br J Cancer 71(3):578–582
Yoneda T (2000) Cellular and molecular basis of preferential metastasis of breast cancer to bone. J Orthop Sci 5:75
Yoneda A, Couchman JR (2003) Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans. Matrix Biol 22:25
Yoneda A, Lendorf ME, Couchman JR, Multhaupt HAB (2012) Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans. J Histochem Cytochem 60:9
Yoshiba N, Yoshiba K, Hosoya A et al (2007) Association of TIMP-2 with extracellular matrix exposed to mechanical stress and its co-distribution with periostin during mouse mandible development. Cell Tissue Res 330:133. https://doi.org/10.1007/s00441-007-0439-x
Yoshioka N, Fuji S, Shimakage M et al (2002) Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Exp Cell Res 279:91. https://doi.org/10.1006/excr.2002.5590
Yu L, Favoino E, Wang Y et al (2011) The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells. Immunol Res 50:294. https://doi.org/10.1007/s12026-011-8232-z
Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584. https://doi.org/10.1126/science.1228522
Zahir N, Lakins JN, Russell A et al (2003) Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163:1397. https://doi.org/10.1083/jcb.200302023
Zaman MH, Trapani LM, Sieminski AL et al (2006) Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc Natl Acad Sci 103:10889. https://doi.org/10.1073/pnas.0604460103
Zernichow L, Abrink M, Hallgren J et al (2006) Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor alpha secretion in response to lipopolysaccharide. J Biol Chem 281(37):26792–26801
Zhang X, Kazerounian S, Duquette M et al (2009) Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J 23:3368. https://doi.org/10.1096/fj.09-131649
Zhang Y, Zhang G, Li J et al (2010a) The expression analysis of periostin in human breast cancer. J Surg Res 160:102. https://doi.org/10.1016/j.jss.2008.12.042
Zhang L, Yang M, Yang D, Cavey G, Davidson P, Gibson G (2010b) Molecular interactions of MMP-13 C-terminal domain with chondrocyte proteins. Connect Tissue Res 51:230–239
Zhang H, Bie P, Leida Z, Xia Z, Bai L (2014) NG2/CSPG4 proteoglycan as a novel prognostic indicator and therapeutic target in malignant cancer. J Stem Cell Res Ther 4:171
Zhao B, Sun T, Meng F et al (2011) Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer. J Cancer Res Clin Oncol 137:1061. https://doi.org/10.1007/s00432-010-0968-7
Zhou Z, Qutaish M, Han Z et al (2015) MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent. Nat Commun 6:7984. https://doi.org/10.1038/ncomms8984
Zhu JX, Goldoni S, Bix G et al (2005) Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 280:32468. https://doi.org/10.1074/jbc.M503833200
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rigoglio, N.N. et al. (2020). The Tumor Microenvironment: Focus on Extracellular Matrix. In: Birbrair, A. (eds) Tumor Microenvironment. Advances in Experimental Medicine and Biology, vol 1245. Springer, Cham. https://doi.org/10.1007/978-3-030-40146-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-40146-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-40145-0
Online ISBN: 978-3-030-40146-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)